Klaria Pharma Holding
0.79 SEK
-7.65 %
Less than 1K followers
KLAR
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
-7.65 %
-20.63 %
+3.29 %
+17.87 %
+53.92 %
-9.92 %
+87.28 %
-91.00 %
-82.82 %
Klaria Pharma Holding operates in the pharmaceutical industry. The business is focused on developing and commercializing solutions in the therapeutic areas of migraine and cancer-related pain. The technology is based on the company's drug-delivery platform, where the product consists of an alginate-based polymer film. The film is attached to the patient's oral mucosa, which enables the distribution of drugs in the body. The headquarters are located in Uppsala.
Read moreMarket cap
193.09M SEK
Turnover
1.4M SEK
Revenue
8.99M
EBIT %
-280.72 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
26.5
2026
General meeting '26
27.8
2026
Interim report Q2'26
26.11
2026
Interim report Q3'26
All
Press releases
ShowingAll content types
Klaria Pharma Holding AB: Klaria postpones publication of the annual report
Notice of the Annual General Meeting of Klaria Pharma Holding AB (publ)
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools